title: Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction.
abstract: By adapting to the actual patient anatomy during treatment, tracked multi-leaf collimator (MLC) treatment deliveries offer an opportunity for margin reduction and healthy tissue sparing. This is assumed to be especially relevant for hypofractionated protocols in which intrafractional motion does not easily average out. In order to confidently deliver tracked treatments with potentially reduced margins, it is necessary to monitor not only the patient anatomy but also the actually delivered dose during irradiation. In this study, we present a novel real-time online dose reconstruction tool which calculates actually delivered dose based on pre-calculated dose influence data in less than 10 ms at a rate of 25 Hz. Using this tool we investigate the impact of clinical target volume (CTV) to planning target volume (PTV) margins on CTV coverage and organ-at-risk dose. On our research linear accelerator, a set of four different CTV-to-PTV margins were tested for three patient cases subject to four different motion conditions. Based on this data, we can conclude that tracking eliminates dose cold spots which can occur in the CTV during conventional deliveries even for the smallest CTV-to-PTV margin of 1 mm. Changes of organ-at-risk dose do occur frequently during MLC tracking and are not negligible in some cases. Intrafractional dose reconstruction is expected to become an important element in any attempt of re-planning the treatment plan during the delivery based on the observed anatomy of the day.
authors.affiliation: Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK.
authors.forename: M F
authors.initials: MF
authors.lastname: Fast
authors.forename: C P
authors.initials: CP
authors.lastname: Kamerling
authors.forename: P
authors.initials: P
authors.lastname: Ziegenhein
authors.forename: M J
authors.initials: MJ
authors.lastname: Menten
authors.forename: J L
authors.initials: JL
authors.lastname: Bedford
authors.forename: S
authors.initials: S
authors.lastname: Nill
authors.forename: U
authors.initials: U
authors.lastname: Oelfke
mesh_terms: D006801:Humans; D008297:Male; D009038:Motion; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D020266:Radiotherapy, Conformal / Q000379:methods*
references.citation: Med Phys. 2012 Jan;39(1):109-18
references.pmid: 22225280
references.citation: Med Phys. 2012 Oct;39(10):6237-46
references.pmid: 23039659
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):914-23
references.pmid: 19910138
references.citation: Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):41-50
references.pmid: 17996391
references.citation: Med Phys. 2010 Dec;37(12 ):6357-67
references.pmid: 21302793
references.citation: Med Phys. 1999 May;26(5):715-20
references.pmid: 10360531
references.citation: Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1038-44
references.pmid: 23021439
references.citation: J Appl Clin Med Phys. 2013 May 06;14(2):4136
references.pmid: 23470941
references.citation: Urology. 2000 Mar;55(3):382-6
references.pmid: 10699615
references.citation: Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):312-20
references.pmid: 20615630
references.citation: Int J Radiat Oncol Biol Phys. 2015 Aug 1;92 (5):1141-1147
references.pmid: 26194684
references.citation: Phys Med Biol. 2010 Jul 21;55(14):4187-202
references.pmid: 20601779
references.citation: Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e655-61
references.pmid: 22975613
references.citation: Phys Med Biol. 2001 Jan;46(1):1-10
references.pmid: 11197664
references.citation: Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1084-90
references.pmid: 18280057
references.citation: Med Phys. 2010 Feb;37(2):753-61
references.pmid: 20229885
references.citation: Med Phys. 2003 Aug;30(8):2065-71
references.pmid: 12945972
references.citation: Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1608-17
references.pmid: 17919845
references.citation: Med Phys. 2014 Feb;41(2):020702
references.pmid: 24506591
references.citation: Med Phys. 2013 May;40(5):051718
references.pmid: 23635266
references.citation: Phys Med Biol. 2015 Aug 7;60(15):6097-111
references.pmid: 26216484
references.citation: Phys Med Biol. 2013 Jun 7;58(11):3705-15
references.pmid: 23656861
references.citation: Med Phys. 2013 Nov;40(11):111723
references.pmid: 24320431
references.citation: Radiother Oncol. 2005 Feb;74(2):177-85
references.pmid: 15734206
references.citation: Phys Med Biol. 2012 Dec 7;57(23):7863-72
references.pmid: 23151821
references.citation: Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):579-87
references.pmid: 20656420
references.citation: Semin Radiat Oncol. 2004 Jan;14(1):52-64
references.pmid: 14752733
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):388-91
references.pmid: 19056185
references.citation: Med Phys. 2014 Nov;41(11):111719
references.pmid: 25370633
references.citation: Phys Med Biol. 2008 May 7;53(9):N157-64
references.pmid: 18401066
references.citation: Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1624-32
references.pmid: 22209149
references.citation: Phys Med Biol. 2014 Dec 7;59(23):7279-96
references.pmid: 25383729
references.citation: Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e545-53
references.pmid: 22014957